Clinical trial NCT02876367: The Clinical Epidemiology of Scrub Typhus in Humans, Chiggers and Rodents
Official title: The Clinical Epidemiology of Scrub Typhus in Humans, Chiggers and Rodents
Study type: OBSERVATIONAL
Overall status: COMPLETED
Conditions: Scrub Typhus
Keywords: Epidemiology
Lead sponsor: University of Oxford
Sponsor class: OTHER
Collaborators: name: Mahidol Oxford Tropical Medicine Research Unit
name: Lao-Oxford-Mahosot Hospital Wellcome Trust Research Unit
name: Wellcome Trust
name: Centre National de la Recherche Scientifique, France
First posted: 2016-08-23
Enrollment: 1200
Sex: ALL
Minimum age (years): 10
Standard ages: CHILD
ADULT
OLDER_ADULT
Accepts healthy volunteers: yes
Observational model: COHORT
Time perspective: PROSPECTIVE
Sampling method: NON_PROBABILITY_SAMPLE
Study population: Group 1 Male or Female, aged 10 years or above, presenting with a fever

Group 2 Male or Female, aged 10 years or above, living in an identified scrub typhus environment

Brief summary: This study to collect and identify rodents and mites across transects through diverse habitats used by the human community from a localised area identified as a scrub typhus 'hot spot'.

Detailed description: Study design:

The project will undertake a detailed investigation of one human community, and its environment, at risk of scrub typhus:

Chiggers, Rodents \& Habitat Study:

Transects across diverse habitats determining spatial distribution of species of chiggers and rodents. This will be performed 3x/year.

High-resolution habitat mapping. Comparison of genomes of O. tsutsugamushi detected in different environments, using attempted WGS.

Village Cohort Study:

Follow a cohort of villagers over 2 years screening all febrile patients for scrub typhus and determining seroconversion rates and infecting O. tsutsugamushi genotypes.

Procedures:

* Mites:

Working with ecology/GIS collaborators, the environment of the community will be mapped and transects laid across the diverse habitats used by the community. Free-living mites will be collected with black plastic plates and black cloth21, from soil using Berlese funnels and from rodents. Trombiculid mites will be identified to genus and a subset to species.

DNA will be extracted from individual chiggers, and qPCR screening for O. tsutsugamushi-positivity performed (real-time PCR targeting 47kDa-gene). A proportion of confirmed positives will undergo genotyping by attempted whole-genome sequencing (WGS).

* Rodents:

Rodents will be captured alive along transects and identified in collaboration with University of Montpellier24. All mites will be removed from rodents, the rodents killed and the rodent spleen and liver collected for O. tsutsugamushi qPCR screening. A proportion of O. tsutsugamushi-positive samples will undergo genotyping by attempted WGS or extended MLST analysis.

* Human cohort:

All those in the community (\>10 years old) will be approached and asked for consent to participate. All enrolled will have scrub typhus ELISA/IFA (from finger-prick filter paper blood spots) performed every 4 months over 2 years to estimate the rates and dynamics of seroconversion. A brief questionnaire will be administered at each visit to determine whether the participant had a febrile illness in the preceding 4 months.

Patients presenting with a febrile illness to local healthcare facilities will be clinically assessed and an on-site scrub typhus IgM rapid diagnostic test (RDT) performed. RDT positive patients will be recruited into the study, and paired acute/convalescent samples sent to LOMWRU for ELISA, qPCR and BSL3 culture, followed by genotyping by attempted WGS. A questionnaire will be administered to recruited patients to determine symptomatology and vital signs recorded.

Epidemiology \& Ecology:

The exact sample collection locations and habitat details will be recorded.

Genomic analyses:

To characterize the relationships between highly diverse O. tsutsugamushi genotypes in multiple strain/genotype-infected hosts a proportion of qPCR positives (approx. 480 samples) will be analysed by whole-genome sequencing at WTCHG in Oxford.

Eligibility criteria: Inclusion Criteria:

Acute scrub typhus (Group 1)

1. Presenting with fever \>38 C and testing positive by scrub typhus RDT.
2. Male or Female, aged 10 years or above.
3. Participant is willing and able to give informed consent for participation in the study.

Scrub typhus serosurvey (Group 2)

1. Villagers living in an environment in which scrub typhus is known to be present, who are asymptomatic.
2. Male or Female, aged 10 years or above.
3. Participant is willing and able to give informed consent for participation in the study.

Exclusion Criteria:

Acute scrub typhus (Group 1)

1. Villagers/patients under 10 years of age.
2. Those unwilling to give written informed consent.

Scrub typhus serosurvey (Group 2)

1. Villagers/patients under 10 years of age.
2. Those unwilling to give written informed consent.

Primary outcomes:
measure: determine the diversity of O. tsutsugamushi genotypes infecting rodents and mites and link these to their geographical distribution and associated habitat characteristics.
timeFrame: up to 24 months
measure: Correlate the frequency of O. tsutsugamushi in mites and rodents with habitat characteristics, to define interactions between distribution and transmission dynamics.
timeFrame: up to 24 months
measure: Identify key mite vectors and rodent hosts involved in scrub typhus natural history, human infection, and disease virulence
timeFrame: up to 24 months
Secondary outcomes:
measure: Determine changes in scrub typhus antibody titres over time and identify acutely infected scrub typhus cases
timeFrame: up to 24 months
measure: Identify human-derived O. tsutsugamushi genotypes to define genomic relationships between human, rodent and mite-derived genotypes.
timeFrame: up to 24 months
measure: Identify putative determinants of human infection/virulence
timeFrame: up to 24 months
measure: To interlink the distribution of O. tsutsugamushi positive mites, rodents and humans with habitat characteristics to propose interventions to reduce the risk of human disease.
timeFrame: up to 24 months
Other outcomes:
Locations:
Study officials:
References: